SF3B1 Mutations in CLL Are Equivalent to p53/ATM Dysfunction and Cause Defective Puma Upregulation in Response to Chemotherapy

被引：4
|
作者：
te Raa, Doreen [1 ]
Derks, Ingrid A. M. [1 ]
Luijks, Dieuwertje M. [1 ]
van Laar, Jacoline [1 ]
Monsuur, Hanneke [1 ]
Oldreive, Ceri [2 ]
Jethwa, Alexander [3 ,4 ]
Huellein, Jennifer [3 ,4 ]
Stankovic, Tatjana [2 ]
Zenz, Thorsten [5 ]
Van Oers, Marinus H. J. [1 ]
Kater, Arnon P. [1 ]
Eldering, Eric [1 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England
[3] Natl Ctr Tumor Dis, Dept Translat Oncol, Heidelberg, Germany
[4] German Canc Res Ctr, Heidelberg, Germany
[5] Heidelberg Univ, Heidelberg, Germany
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.711.711
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
711
引用
收藏
页数：2
相关论文
共 50 条
  • [1] SF3B1 MUTATIONS IN CLL ARE FUNCTIONALLY EQUIVALENT TO ATM GENE ALTERATIONS AND CAUSE DEFECTIVE PUMA AND P21 UPREGULATION IN RESPONSE TO DNA DAMAGE
    Raa, D.
    Derks, I.
    van Laar, J.
    Monsuur, H.
    Luijks, D.
    Navrkalova, V.
    Malcikova, J.
    Trbusek, M.
    Jethwa, A.
    Huellein, J.
    Geisler, C.
    Zenz, T.
    Pospisilova, S.
    Stankovic, T.
    Van Oers, M.
    Kater, A.
    Eldering, E.
    HAEMATOLOGICA, 2013, 98 : 33 - 33
  • [2] SF3B1 MUTATIONS IN CLL ARE ASSOCIATED WITH A DEFECTIVE DNA DAMAGE RESPONSE
    Eldering, E.
    te Raa, D.
    Derks, I.
    Navrkalova, V.
    Skowronska, A.
    Oldreive, C.
    Moerland, P.
    Malcikova, J.
    Trbusek, M.
    Hullein, J.
    Jethwa, A.
    Zenz, T.
    Pospisilova, S.
    Stankovic, T.
    van Oers, M.
    Kater, A.
    HAEMATOLOGICA, 2014, 99 : 315 - 316
  • [3] SF3B1 Mutations Frequently Occur With Both ATM Mutations and TP53 Mutations In CLL Patients
    Navrkalova, Veronika
    Malcikova, Jitka
    Kantorova, Barbara
    Sebejova, Ludmila
    Plevova, Karla
    Mraz, Marek
    Doubek, Michael
    Brychtova, Yvona
    Smardova, Jana
    Mayer, Jiri
    Pospisilova, Sarka
    Trbusek, Martin
    BLOOD, 2013, 122 (21)
  • [4] COOPERATION BETWEEN SF3B1 MUTATIONS AND ATM DELETION IN CLL DEVELOPMENT
    Cusan, Martina
    Hart, Kevyn
    Iyer, Prajish
    Wang, Lili
    EXPERIMENTAL HEMATOLOGY, 2018, 64 : S60 - S60
  • [5] The impact of SF3B1 mutations in CLL on the DNA-damage response
    G D te Raa
    I A M Derks
    V Navrkalova
    A Skowronska
    P D Moerland
    J van Laar
    C Oldreive
    H Monsuur
    M Trbusek
    J Malcikova
    M Lodén
    C H Geisler
    J Hüllein
    A Jethwa
    T Zenz
    S Pospisilova
    T Stankovic
    M H J van Oers
    A P Kater
    E Eldering
    Leukemia, 2015, 29 : 1133 - 1142
  • [6] The impact of SF3B1 mutations in CLL on the DNA-damage response
    te Raa, G. D.
    Derks, I. A. M.
    Navrkalova, V.
    Skowronska, A.
    Moerland, P. D.
    van Laar, J.
    Oldreive, C.
    Monsuur, H.
    Trbusek, M.
    Malcikova, J.
    Loden, M.
    Geisler, C. H.
    Hullein, J.
    Jethwa, A.
    Zenz, T.
    Pospisilova, S.
    Stankovic, T.
    van Oers, M. H. J.
    Kater, A. P.
    Eldering, E.
    LEUKEMIA, 2015, 29 (05) : 1133 - 1142
  • [7] Defective expression of ataxia telangiectasia mutated (ATM) as a cause of p53 dysfunction in B-cell chronic lymphocytic leukemia (CLL).
    Pettitt, AR
    Stankovic, T
    Sherrington, PD
    Stewart, GS
    Cawley, JC
    Taylor, AM
    BLOOD, 1999, 94 (10) : 490A - 490A
  • [8] Cooperation between SF3B1 mutation and ATM deletion in the development of CLL
    Wang, Lili
    Cusan, Martina
    Yin, Shanye
    Jin, Meiling
    Gutierrez, Catherine
    ten Hacken, Elisa
    Herman, Sarah
    Rassenti, Laura
    Ghia, Emanuela
    Kipps, Thomas J.
    Wiestner, Adrian
    Getz, Gad
    Siddiqi, Tanya
    Rosen, Steven
    Wu, Catherine J.
    LEUKEMIA & LYMPHOMA, 2020, 61 : 264 - 265
  • [9] MUTATIONS IN SF3B1 GENE ARE SELECTED INDEPENDENTLY ON ATM/TP53 STATUS AND REDUCE THE TIME TO FIRST TREATMENT IN CLL PATIENTS
    Hlozkova, M.
    Figulova, J.
    Navrkalova, V.
    Malcikova, J.
    Smardova, J.
    Tom, N.
    Brychtova, Y.
    Doubek, M.
    Mayer, J.
    Pospisilova, S.
    Trbusek, M.
    HAEMATOLOGICA, 2016, 101 : 417 - 417
  • [10] SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response
    Bland, Philip
    Saville, Harry
    Wai, Patty T.
    Curnow, Lucinda
    Muirhead, Gareth
    Nieminuszczy, Jadwiga
    Ravindran, Nivedita
    John, Marie Beatrix
    Hedayat, Somaieh
    Barker, Holly E.
    Wright, James
    Yu, Lu
    Mavrommati, Ioanna
    Read, Abigail
    Peck, Barrie
    Allen, Mark
    Gazinska, Patrycja
    Pemberton, Helen N.
    Gulati, Aditi
    Nash, Sarah
    Noor, Farzana
    Guppy, Naomi
    Roxanis, Ioannis
    Pratt, Guy
    Oldreive, Ceri
    Stankovic, Tatjana
    Barlow, Samantha
    Kalirai, Helen
    Coupland, Sarah E.
    Broderick, Ronan
    Alsafadi, Samar
    Houy, Alexandre
    Stern, Marc-Henri
    Pettit, Stephen
    Choudhary, Jyoti S.
    Haider, Syed
    Niedzwiedz, Wojciech
    Lord, Christopher J.
    Natrajan, Rachael
    NATURE GENETICS, 2023, 55 (08) : 1311 - +
12345